Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) Spain
Research
Date range: 1 April 2021 - 31 March 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
8 | 1.10 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 7 | 0.90 |
Chemistry | 1 | 0.20 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.98 | 0.14 | 3.92 | 0.86 | 3.51 |
Compare Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) with other institutions
Collaboration
Date range: 1 April 2021 - 31 March 2022
International vs. domestic collaboration by Share
- 50.75% Domestic
- 49.25% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) by Share (21 total)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Spanish National Research Council (CSIC)
(1.58)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and University of Cantabria (UC)
(1.56)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Sodercan, S.A.
(1.46)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and University of Granada (UGR)
(0.60)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Centre for Genomics and Oncological Research (GENYO)
(0.56)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Instituto de Investigación Biosanitaria de Granada (ibs.Granada)
(0.56)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Hospital Universitario Virgen de las Nieves (HUVN)
(0.56)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Hospitales de Granada
(0.54)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Regional Government of Andalusia
(0.54)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and ALBA Synchrotron
(0.45)
Top 10 international collaborators with Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) by Share (38 total)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and University of Cologne (UoC)
(2.70)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Max Planck Society
(1.17)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Erasmus University Rotterdam (EUR)
(0.72)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Loma Linda University (LLU)
(0.56)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Pfizer Inc.
(0.54)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Centre Hospitalier Universitaire de Lille (CHU Lille)
(0.34)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Helmholtz Association of German Research Centres
(0.30)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Diamond Light Source Ltd.
(0.30)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and University of Göttingen
(0.29)
-
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) and Maladies Rares du Developpement Embryonnaire et du Metabolisme : du Phénotype au Génotype et à la Fonction (RADEME)
(0.28)
Relationships
Partner Institutions
Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.